Analysts have been eager to weigh in on the Healthcare sector with new ratings on Edwards Lifesciences (EW – Research Report), Arrowhead ...

Royal Bank of Canada reissued their outperform rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research report sent to investors on Tuesday,Benzinga reports. They ...

Shillong Night Teer Second Round Winning Number: Shillong Teer Result 2024 are released daily, in two phases. The first-round ...

Q1 2025 Earnings Call Transcript February 10, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-0.42. Chris Anzalone: Thanks, Vince.

Andrew Boelk took aim at what appeared to be a large fish along a water-filled ditch. As he pulled his bow back, his father Keith Boelk stood behind him eyeing the target. “Perfect,” said Keith ...

PASADENA, Calif. - Arrowhead Pharmaceuticals, Inc. (NASDAQ: NASDAQ:ARWR), currently trading at $20.24 and showing an 8% gain over the past week, has finalized its licensing and collaboration agreement ...

Jerry Hokkala didn’t buy his first bow and arrows until he was 40 years old. Despite the late start, he became a record-breaking participant in the sport during the next three decades. And ...